| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 511.64 | 12.8% |
| Total Income | 515.32 | 14.1% |
| Expenditure | 567.51 | 9.7% |
| PBT | -52.19 | 129.2% |
| Net Profit | -57.76 | 140.2% |
| OPM | 3.16% | 37.62pp |
| NPM | -11.21% | 35.15pp |
| EPS | 26.20 | 61.5% |
Sundaram Clayton Reports 16% EBITDA Improvement in Q1 FY 2025-26
06 Aug 2025 · 6 Aug 2025, 01:00 pm
Summary
Sundaram Clayton Limited (SCL) reports a strong EBITDA improvement of 16% with Q1 FY 2025-26 at Rs. 70.6 Cr as against Rs. 61.1 Cr in Q1 2024-25. The standalone revenue for the financial year Q1 2025-26 at Rs. 444.1 Cr as against Rs. 553.6 Cr in Q1 2024-25. The operations have ramped up smoothly at Thervoy Kandigai Plant (TKP), the new plant, without any disruptions. The Company has adopted a strategy to consolidate its 3 plants into 2 plants. The North American market in 2025 has experienced pronounced volatility, but the Company considers it as a long term strategic market with growth opportunities.
Key Highlights
- 1
16% EBITDA improvement in Q1 FY 2025-26
- 2
Standalone revenue at Rs. 444.1 Cr in Q1 FY 2025-26
- 3
Smooth operations at the new Thervoy Kandigai Plant (TKP)
- 4
Consolidation of 3 plants into 2 plants in final stages
- 5
Highest quarterly sales performance of Rs. 79.7 Cr in North American operations
- 6
North America considered as a long term strategic market
Management Comments
Not provided
No specific management comments were provided in the document.
Informational and educational content only. Not investment advice.